FilingIndex
10-K/AThe Record

Immix Biopharma, Inc. files 10-K/A

Filed Mar 27, 2026 · 3mo ago · Accession 0001493152-26-013298

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
IMMX
CIK
1873835
Form type
10-K/A
Filing date
Mar 27, 2026
Report date
Dec 31, 2025
Document
form10-ka.htm
Size
6.3 MB